[go: up one dir, main page]

FI800502A - Difenylhydantoinderivat dessa innehaollande farmaceutiska kompositioner samt foerfarande foer framstaellning av dessa derivat - Google Patents

Difenylhydantoinderivat dessa innehaollande farmaceutiska kompositioner samt foerfarande foer framstaellning av dessa derivat

Info

Publication number
FI800502A
FI800502A FI800502A FI800502A FI800502A FI 800502 A FI800502 A FI 800502A FI 800502 A FI800502 A FI 800502A FI 800502 A FI800502 A FI 800502A FI 800502 A FI800502 A FI 800502A
Authority
FI
Finland
Prior art keywords
dessa
pharmaceutical composition
diphenylhydantoinderivat
derivat
foerfarande foer
Prior art date
Application number
FI800502A
Other languages
English (en)
Other versions
FI71556C (fi
FI71556B (fi
Inventor
Pierre Dumont
Jacques Poupaert
Original Assignee
Inst Nat Des Radioel Nat I Voo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Des Radioel Nat I Voo filed Critical Inst Nat Des Radioel Nat I Voo
Publication of FI800502A publication Critical patent/FI800502A/fi
Application granted granted Critical
Publication of FI71556B publication Critical patent/FI71556B/fi
Publication of FI71556C publication Critical patent/FI71556C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
FI800502A 1979-02-20 1980-02-20 Foerfarande foer framstaellning av 5-(paradeuterofenyl)-5-fenylhydantoin, vilken aer ett laekemedel anvaendbart mot konvulsioner. FI71556C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7904209 1979-02-20
FR7904209A FR2449448B1 (fr) 1979-02-20 1979-02-20 Composition pharmaceutique comprenant un derive de phenylhydantoine, derives mis en oeuvre et leur preparation

Publications (3)

Publication Number Publication Date
FI800502A true FI800502A (fi) 1980-08-21
FI71556B FI71556B (fi) 1986-10-10
FI71556C FI71556C (fi) 1987-01-19

Family

ID=9222166

Family Applications (1)

Application Number Title Priority Date Filing Date
FI800502A FI71556C (fi) 1979-02-20 1980-02-20 Foerfarande foer framstaellning av 5-(paradeuterofenyl)-5-fenylhydantoin, vilken aer ett laekemedel anvaendbart mot konvulsioner.

Country Status (11)

Country Link
US (1) US4304782A (fi)
EP (1) EP0015038B1 (fi)
JP (1) JPS55133362A (fi)
AT (1) ATE10804T1 (fi)
CA (1) CA1139672A (fi)
DE (1) DE3069813D1 (fi)
DK (1) DK71780A (fi)
ES (1) ES488788A0 (fi)
FI (1) FI71556C (fi)
FR (1) FR2449448B1 (fi)
NO (1) NO152047C (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106837B2 (ja) * 1989-01-31 1995-11-15 シャープ株式会社 シート状体の循環式供給装置
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
JPH04297461A (ja) * 1991-03-27 1992-10-21 Otsuka Pharmaceut Factory Inc 2−チオヒダントイン誘導体
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
EP0751926B1 (en) * 1994-03-25 2007-09-12 Isotechnika,Inc. Enhancement of the efficacy of drugs by deuteration
WO1999048876A1 (en) * 1998-03-20 1999-09-30 Warner-Lambert Company Crystalline sodium phenytoin monohydrate
AU757290B2 (en) * 1998-03-25 2003-02-13 Bristol-Myers Squibb Company Imidazolone anorectic agents: II. phenyl derivatives
DE10214228A1 (de) * 2002-03-22 2003-10-02 Bdd Group Holding Ag Zug Deuterierte substitutierte Indole sowie diese Verbindungen enthaltende Arzneimittel
EP2299266A1 (en) * 2003-12-19 2011-03-23 The Regents of the University of California Methods and materials for assessing prostate cancer therapies
AU2005232526B2 (en) * 2004-02-24 2011-06-23 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
ES2588606T3 (es) 2006-03-27 2016-11-03 The Regents Of The University Of California Modulador del receptor de andrógenos para el tratamiento del cáncer de próstata y enfermedades asociadas con el receptor de andrógenos
KR20160027254A (ko) 2006-03-29 2016-03-09 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
US8680291B2 (en) 2007-10-26 2014-03-25 The Regents Of The University Of California Diarylhydantoin compounds
EA023981B1 (ru) 2010-02-16 2016-08-31 Арагон Фармасьютикалс, Инк. Модуляторы рецептора андрогенов и их применение
EA037806B1 (ru) 2012-09-26 2021-05-24 Арагон Фармасьютикалз, Инк. Способ лечения неметастатического кастрационно-резистентного рака простаты
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
WO2019078920A1 (en) 2017-10-16 2019-04-25 Aragon Pharmaceuticals, Inc. ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC RESISTANT PROSTATE CANCER

Also Published As

Publication number Publication date
FI71556C (fi) 1987-01-19
FR2449448A1 (fr) 1980-09-19
FI71556B (fi) 1986-10-10
ATE10804T1 (de) 1985-01-15
CA1139672A (en) 1983-01-18
EP0015038A1 (fr) 1980-09-03
US4304782A (en) 1981-12-08
NO152047B (no) 1985-04-15
DK71780A (da) 1980-08-21
JPS55133362A (en) 1980-10-17
EP0015038B1 (fr) 1984-12-19
ES8200011A1 (es) 1981-10-16
DE3069813D1 (en) 1985-01-31
NO800447L (no) 1980-08-21
NO152047C (no) 1985-07-24
ES488788A0 (es) 1981-10-16
FR2449448B1 (fr) 1983-05-27

Similar Documents

Publication Publication Date Title
FI800502A (fi) Difenylhydantoinderivat dessa innehaollande farmaceutiska kompositioner samt foerfarande foer framstaellning av dessa derivat
ES2070186T3 (es) Nuevos derivados de 2,4-diamino-pirimidina-3-oxido y su utilizacion en la prevencion de la caida de los cabellos.
ATE45579T1 (de) Diazabicyclo-(3,3,1)-nonane.
SE7704256L (sv) Nya substituerade fluoracylresorcin for lekemedel, kosmetika och pesticider samt forfarande for framstellning derav
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
SE7710755L (sv) Forfarande for framstellning av foreningar med analgetisk verkan
MX9203243A (es) Oxazolidinonas y composiciones farmaceuticas que las contienen.
DK429089D0 (da) Alkylbenzylaminer
NO172437C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
SE8006953L (sv) Heterocykliska foreningar
ATE113030T1 (de) Hydroxyalkancarbonsäure-derivate und deren verwendung.
EP1056700A4 (en) MEDICAL APPLICATIONS OF PHENYL ALCOHOLS AND DERIVATIVES THEREOF
SE7403176L (fi)
FI800057A (fi) Foerfarande foer framstaellning av hexahydro-1,4-oxazepin
PT90262A (pt) Processo para a preparacao de novos derivados trienicos com estrutura cromenica
IL60176A (en) (aminopiperidinopropyl)dimethyl xanthine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
ES2060095T3 (es) Nuevas imidazobenzodiazepinas y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que los contienen.
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
MX22863A (es) Procedimiento de preparacion de nuevos derivados sustituidos en posicion 15 de la 20,21-dinoreburnamenina.
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media
DK0483063T3 (da) Ergolinderivater
SE7710841L (sv) Anhydro socker
NZ329511A (en) Elliticine derivatives and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: REGION WALLONNE REPRESENTEE PAR